J. Breitmeyer

发表

Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates NK cells at lower concentrations and more effectively than rituximab.

Brian J. Smith, G. Weiner, J. Wooldridge, 2005, Blood.

Adjuvant systemic therapy for patients with node‐negative tumors

S. Love, L. Parker, J. Garber, 1990, Cancer.

Adjuvant chemotherapy of breast cancer.

I. Henderson, J. Breitmeyer, 1990, The Surgical clinics of North America.

FcR-mediated crosslinking of Ta1 (CDw26) induces human T lymphocyte activation.

D. Hafler, N. Dang, S. Schlossman, 1990, Cellular immunology.

Comprehensive management of disseminated breast cancer

J. Garber, D. Hayes, J. Harris, 1990, Cancer.

Regulatory interactions between members of the immunoglobulin superfamily.

P. Anderson, C. Morimoto, Chika Morimoto, 1988, Immunology today.

Childhood asthma and use during pregnancy of acetaminophen. A critical review.

M. Royal, A. Scialli, J. Breitmeyer, 2010, Reproductive toxicology.

Genetic reconstitution of the T cell receptor (TcR) α/β heterodimer restores the association of CD3 ζ2 with the TcR/CD3 complex

S. Ley, R. Blumberg, C. Terhorst, 1991 .

Mechanisms of immune memory. T cell activation and CD3 phosphorylation correlates with Ta1 (CDw26) expression.

D. Hafler, N. Dang, J. Breitmeyer, 1989, Journal of immunology.

Poxvirus-based active immunotherapy synergizes with CTLA-4 blockade to increase survival in a murine tumor model by improving the magnitude and quality of cytotoxic T cells

S. Mandl, Susan P. Foy, R. Rountree, 2016, Cancer Immunology, Immunotherapy.

Assembly of the human T cell receptor-CD3 complex takes place in the endoplasmic reticulum and involves intermediary complexes between the CD3-gamma.delta.epsilon core and single T cell receptor alpha or beta chains.

B. Berkhout, B. Alarcón, C. Terhorst, 1988, The Journal of biological chemistry.

A second specific endonuclease from Haemophilus aegyptius.

R. Roberts, J. Breitmeyer, N. Tabachnik, 1975, Journal of molecular biology.

Abnormal T-Lymphocyte Subsets in Type I Diabetes

G. Eisenbarth, J. Daley, D. Faustman, 1989, Diabetes.

Analysis of T lymphocyte subsets in all stages of diabetes.

G. Eisenbarth, D. Faustman, J. Breitmeyer, 1990, Journal of autoimmunity.

Recombinant Human Interferon-β (rHuIFN-β) and Radiation Therapy for Inoperable Non-Small Cell Lung Cancer

E. Borden, L. Vaickus, C. Lawton, 1996 .

Platelet transfusion and alternatives to transfusion in patients with malignancy

L. Vaickus, J. Breitmeyer, K. Anderson, 1995, Stem cells.

Affinity labeling of specific regions of 23 S RNA by reaction of N-bromoacetyl-phenylalanyl-transfer RNA with Escherichia coli ribosomes.

H. Noller, J. Breitmeyer, 1976, Journal of molecular biology.

Poxvirus-based active immunotherapy synergizes with immune checkpoint inhibitors to cause tumor regression and extend survival in preclinical models of cancer

S. Mandl, Susan P. Foy, R. Rountree, 2014, Journal of Immunotherapy for Cancer.

Cloning of the bovine 215-kDa cation-independent mannose 6-phosphate receptor.

J. Chirgwin, S. Kornfeld, P. Lobel, 1987, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of T cell clone function via CD4 and CD8 molecules. Anti-CD4 can mediate two distinct inhibitory activities.

D. Hafler, J. Daley, M. Blue, 1988, Journal of immunology.

The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells.

J. Daley, S. Schlossman, J. Breitmeyer, 1987, Journal of immunology.

The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells

D. Marsh, C. Ford, G. Kaufmann, 2022, Pharmaceutics.

46 kd mannose 6-phosphate receptor: Cloning, expression, and homology to the 215 kd mannose 6-phosphate receptor

J. Chirgwin, S. Kornfeld, P. Lobel, 1987, Cell.

Sheep erythrocyte rosetting induces multiple alterations in T lymphocyte function: inhibition of T cell receptor activity and stimulation of T11/CD2.

D. Faustman, J. Breitmeyer, 1989, Cellular immunology.

A review of the literature on the effects of acetaminophen on pregnancy outcome.

M. Royal, A. Scialli, J. Breitmeyer, 2010, Reproductive toxicology.

Growth inhibition of human T cells by antibodies recognizing the T cell antigen receptor complex.

J. Daley, S. Schlossman, J. Breitmeyer, 1987, Journal of immunology.

A randomized, double-blind, placebo-controlled, multicenter, repeat-dose study of two intravenous acetaminophen dosing regimens for the treatment of pain after abdominal laparoscopic surgery.

M. Royal, N. Singla, H. Minkowitz, 2010, Clinical therapeutics.

A phase I study of recombinant interferon-beta in patients with advanced malignant disease.

Z. Estrov, R. Kurzrock, F. Ravandi, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

A randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever.

M. Royal, W. Peacock, William B. Smith, 2011, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

Immunotherapy of breast cancer.

J. Breitmeyer, 1992, Cancer treatment and research.

Safety and Efficacy of Intravenous Acetaminophen in the Elderly After Major Orthopedic Surgery: Subset Data Analysis From 3, Randomized, Placebo-Controlled Trials

M. Royal, J. Breitmeyer, J. Jahr, 2012, American journal of therapeutics.

Recombinant Human Growth Hormone in Patients with HIV-Associated Wasting

A. LaMarca, Jack Wang, M. Schambelan, 1996, Annals of Internal Medicine.

NK cells at lower concentrations and more effectively than rituximab Anti-CD20 monoclonal antibody with enhanced affinity for CD16 activates

Brian J. Smith, J. George, B. Link, 2013 .

How T cells communicate

J. Breitmeyer, 1987, Nature.

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

A. LaMarca, J. Wang, M. Schambelan, 1996, Annals of internal medicine.

Assembly and function of the T cell antigen receptor. Requirement of either the lysine or arginine residues in the transmembrane region of the alpha chain.

B. Alarcón, R. Blumberg, C. Terhorst, 1990, The Journal of biological chemistry.

Prospect: A randomized double-blind phase 3 efficacy study of PROSTVAC-VF immunotherapy in men with asymptomatic/minimally symptomatic metastatic castration-resistant prostate cancer.

P. Kantoff, J. Schlom, J. Gulley, 2015 .

Near-Infrared Spectroscopy of Hayabusa Sample Return Capsule Reentry

Peter Jenniskens, Michael J. Taylor, Ronald F. Dantowitz, 2014 .

Time-Resolved Absolute Irradiance of the Hayabusa Sample Return Capsule Reentry

Jay H. Grinstead, Peter Jenniskens, Ronald F. Dantowitz, 2012 .

TK216 for relapsed/refractory Ewing sarcoma: Interim phase 1/2 results.

P. Anderson, R. Riedel, J. Ludwig, 2021 .

Phase 1/2 study of cirmtuzumab and ibrutinib in mantle cell lymphoma (MCL) or chronic lymphocytic leukemia (CLL).

Michael L. Wang, G. Chung, C. Jamieson, 2021 .

Intravenous Acetaminophen for Pain after Major Orthopedic Surgery: An Expanded Analysis

E. Viscusi, M. Royal, R. Sinatra, 2012, Pain practice : the official journal of World Institute of Pain.

Phase 1/2 Study of Zilovertamab and Ibrutinib in Mantle Cell Lymphoma (MCL), Chronic Lymphocytic Leukemia (CLL), or Marginal Zone Lymphoma (MZL)

G. Chung, C. Jamieson, W. Wierda, 2022, Blood.

1620O Phase I study of TK216, a novel anti-ETS agent for Ewing sarcoma

R. Riedel, J. Ludwig, J. Toretsky, 2020 .

Comprehensive management of disseminated breast cancer

D. Hayes, I. Henderson, J. Breitmeyer, 1990, Cancer.

A phase I, first-in-human, dose escalation study of intravenous TK216 in patients with relapsed or refractory Ewing sarcoma.

J. Ludwig, J. Toretsky, N. Daw, 2017 .

Cirmtuzumab, an Anti-ROR1 Antibody, in Combination with Ibrutinib: Clinical Activity in Mantle Cell Lymphoma (MCL) or Chronic Lymphocytic Leukemia (CLL) from a Phase 1/2 Study

Michael L. Wang, T. Kipps, G. Chung, 2020 .

Phase 1/2 trial of cirmtuzumab and ibrutinib: Planned analysis of phase 1 CLL cohorts.

T. Kipps, C. Jamieson, W. Wierda, 2019, Journal of Clinical Oncology.